Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Operating Leases: 2020-2025

Historic Operating Leases for BIO-TECHNE (TECH) over the last 6 years, with Jun 2025 value amounting to $84.0 million.

  • BIO-TECHNE's Operating Leases fell 5.54% to $80.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.7 million, marking a year-over-year decrease of 5.54%. This contributed to the annual value of $84.0 million for FY2025, which is 4.17% down from last year.
  • According to the latest figures from FY2025, BIO-TECHNE's Operating Leases is $84.0 million, which was down 4.17% from $87.6 million recorded in FY2024.
  • BIO-TECHNE's 5-year Operating Leases high stood at $93.8 million for FY2023, and its period low was $58.1 million during FY2022.
  • For the 3-year period, BIO-TECHNE's Operating Leases averaged around $88.4 million, with its median value being $87.6 million (2024).
  • Its Operating Leases has fluctuated over the past 5 years, first declined by 14.04% in 2022, then soared by 61.30% in 2023.
  • BIO-TECHNE's Operating Leases (Yearly) stood at $67.6 million in 2021, then fell by 14.04% to $58.1 million in 2022, then skyrocketed by 61.30% to $93.8 million in 2023, then declined by 6.56% to $87.6 million in 2024, then fell by 4.17% to $84.0 million in 2025.